<DOC>
	<DOCNO>NCT00778700</DOCNO>
	<brief_summary>The study double-blind , randomize , vehicle-controlled study application INCB018424 phosphate cream vehicle patient stable plaque psoriasis . Application QD 12 week without occlusive dressing . There 4 treatment 50 subject .</brief_summary>
	<brief_title>A Dose Ranging Study Effect INCB018424 Phosphate Cream When Applied Patients With Plaque Psoriasis</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<criteria>Plaque psoriasis involve 2 20 % Body Surface Area Lesions solely involve intertriginious area , scalp face Systemic therapy psoriasis Pustular psoriasis erythroderma Currently topical agent UVB therapy within 2 week first dose study medication Started discontinue therapy within 2 month Screening agent exacerbate psoriasis Receiving systemic triazole antifungal except fluconazole</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2012</verification_date>
</DOC>